EQS-Adhoc: REPLOID Group AG: REPLOID Group AG acquires stake in HEROSAN Healthcare GmbH – strategic focus on sustainable animal feed products and production.

EQS-Ad-hoc: REPLOID Group AG / Key word(s): Mergers &
   Acquisitions/Alliance
   REPLOID Group AG: REPLOID Group AG acquires stake in HEROSAN Healthcare
   GmbH – strategic focus on sustainable animal feed products and production.

   03-Oct-2025 / 12:00 CET/CEST
   Disclosure of an inside information acc. to Article 17 MAR of the
   Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS
   Group.
   The issuer is solely responsible for the content of this announcement.

   ══════════════════════════════════════════════════════════════════════════

   Wels, 3 October 2025
   REPLOID Group AG announces that it is acquiring a stake in HEROSAN
   Healthcare GmbH, thereby expanding its involvement in the fast-growing
   markets for sustainable animal feed products and production. The
   acquisition of the company will take place in two phases. In 2025, REPLOID
   Group AG will acquire more than 30% of the company's shares, with a view
   to increasing its stake to 100% in 2026 via a notarised ‘step-up option’. 

   HEROSAN pursues a clear, Europe-wide growth strategy focused on
   sustainability, responsibility and healthy animal nutrition. With a wide
   range of products from feed mixes with hemp and insect protein to
   functional mushroom components and selected meat products, HEROSAN
   positions itself as a supplier of a high-quality premium product range for
   pets in specialist shops, food retailers and e-commerce.

   With its entry into HEROSAN, REPLOID Group AG is strategically expanding
   its investment portfolio to include a company with very strong growth
   potential in a promising market segment. The aim of this investment and
   cooperation is to position HEROSAN as one of Europe's leading feed
   producers in the coming years.
    

   End of Inside Information

   ══════════════════════════════════════════════════════════════════════════

   Information and Explanation of the Issuer to this announcement:

   Important note
   This announcement is a mandatory disclosure of inside information pursuant
   to Article 17 of the Market Abuse Regulation (EU) No 596/2014. It does not
   constitute financial analysis or advice or a recommendation relating to
   financial instruments, nor does it constitute an offer, solicitation or
   invitation to buy or sell securities of REPLOID Group AG.
    

   Issuer            REPLOID Group AG
                     Maria-Theresia-Straße 53/2 OG
                     4600 Wels
                     Austria
   Contact           Philip Pauer
                     CEO REPLOID Group AG
   Tel.              +43 660 4755556
   Email             investors@reploid.eu
   Website:          https://reploid.eu/
   ISIN(s):          AT0000A3HRX5 (share)
   Stock exchange(s) Vienna Stock Exchange (Direct Market Plus)

   ══════════════════════════════════════════════════════════════════════════

   03-Oct-2025 CET/CEST News transmitted by EQS Group. www.eqs.com

   ══════════════════════════════════════════════════════════════════════════

   Language:    English
   Company:     REPLOID Group AG
                Maria-Theresia-Straße 53
                4600 Wels
                Austria
   Phone:       +43 660 / 776 50 40
   E-mail:      office@reploid.eu
   Internet:    reploid.eu
   ISIN:        AT0000A3HRX5
   Listed:      Vienna Stock Exchange (Vienna MTF)
   EQS News ID: 2207210

   IPO geplant, IPO planned;

    
   End of Announcement EQS News Service


   2207210  03-Oct-2025 CET/CEST

   https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=2207210&application_name=news&site_id=apa_ots_austria~~~18b544d0-9c71-4160-bd95-cc8b9aff9fbf

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS - WWW.OTS.AT |

print